QA: Assembly Biosciences INC in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001426800_2022_Assembly_Biosciences_INC.pdf

Logs

Graph

Absolute values for 0001426800, Assembly Biosciences INC

  xvar xval
0 AssetsCurrent 154,204,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,139,000
3 remainder_Assets 35,717,000
4 LiabilitiesCurrent 16,073,000
5 LiabilitiesNoncurrent 6,058,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 29,444,119
9 ResearchAndDevelopmentExpense 65,634,517
10 remainder_Expenses 232,064,769
11 remainder_Revenues 78,696,362
12 remainder_NetIncome -1,269,433
13 remainder_ComprehensiveNetIncome -149,041
  yvar yval
0 Assets 191,060,000
1 Liabilities 22,131,000
2 Expenses 327,143,405
3 Revenues 78,696,362
4 StockholdersEquity 168,929,000
5 NetIncome -249,716,476
6 ComprehensiveNetIncome -249,790,996
7 BaseVar 310,224,620
8 EconomicCapitalRatiobeforeLimitedLiability 1.11
9 EconomicCapitalRatio 2.39

Edgar->Model Mapping

Feature Distribution

Change over Time